Substance Use DisordersPhase 3NCT01085188
Effectiveness of Assertive Continuing Care for Youth
A Phase 3 study testing ACC, CM and UCC in people with Substance Use Disorders, run by Chestnut Health Systems.
Trial summary
Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design. Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge. Read more about this study
- Who is it for?
- Ages 12 to 18 years
- Conditions the study is for
- Substance Use Disorders
- What is being tested?
- ACC, CM and UCC
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 342 participants
- Where
- No sites listed yet
- Study dates
- Jan 2003to Jan 2008
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Met DSM-IV diagnostic criteria for abuse or dependence on alcohol or another drug in the past year
- Been between the ages of 12 and 18 at the time of residential admission; and (c) resided in one of ten Illinois counties targeted for the intervention
Who cannot join
- left residential treatment prior to the seventh day
- did not return to a target county at discharge
- showed evidence of cognitive impairment that interfered with understanding of study instruments, procedures, or the informed consent process
- were deemed dangerous to themselves or others during treatment
- were a ward of child protective services and inaccessible for the intervention
- met DSM-IV criteria for pathological gambling
- were discharged to the state department of corrections
- were already participating in a treatment study
About this study
Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design. Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge.
- Conditions
- Substance Use Disorders
- Being tested
- ACC, CM, UCC
- Medical subject headings
- Substance-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ACCBehavioural
Weekly community based behavioral counseling and case management
CMBehavioural
Weekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results
UCCBehavioural
recommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic.
| Study group | Role | What they receive |
|---|---|---|
| Assertive Continuing Care (ACC) | Experimental | Behavioral intervention comprised of the community reinforcement approach plus case management delivered in home and other community settings to youth and their caregivers. Receives: Behavioral: ACC; Behavioral: UCC |
| Contingency Management (CM) | Experimental | Using a prize drawing system (no, low, medium and large value prizes) with adolescents could earn escalating prize drawing opportunities by completing verifiable pro-social activities and providing negative urine test and breath alcohol test results. Receives: Behavioral: CM; Behavioral: UCC |
| ACC + CM | Experimental | This arm is the combination of arms 1 and 2. Receives: Behavioral: ACC; Behavioral: CM; Behavioral: UCC |
| Usual Continuing Care (UCC) | Active comparator | UCC consists of a discharge recommendation to seek aftercare services at nearest treatment provider to where the patient lived. This service primarily consisted of outpatient group counseling. Receives: Behavioral: UCC |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2010 (estimated)
- Study startJan 2003
- Primary completionJan 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance Use DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Enrolment
- 342 participants (actual)
Sponsor and investigators
- Lead sponsor
- Chestnut Health Systems
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01085188
- Sponsor's protocol ID
- 1018-1201
- Status last verified
- Mar 2010
- First submitted
- 10 Mar 2010
- Last updated
- 11 Mar 2010
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Assertive Continuing Care for Youth
- ClinicalTrials.gov ID
- NCT01085188
- Acronym / sponsor ID
- 1018-1201
- Conditions
- Substance Use Disorders
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 342 participants (actual)
- Lead sponsor
- Chestnut Health SystemsUniversity, hospital or other
- Collaborators
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Study start
- Jan 2003
- Primary completion
- Jan 2008 (actual)
- First posted
- 11 Mar 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Following discharge from residential treatment 324 adolescents are randomly assigned to Assertive Continuing Care with and without motivational incentives in a 2 x 2 factorial design. Clinical outcomes are assessed at 3, 6, 9, and 12 months post discharge.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Assertive Continuing Care (ACC) | Experimental | Behavioral: ACC, Behavioral: UCCBehavioral intervention comprised of the community reinforcement approach plus case management delivered in home and other community settings to youth and their caregivers. |
| Contingency Management (CM) | Experimental | Behavioral: CM, Behavioral: UCCUsing a prize drawing system (no, low, medium and large value prizes) with adolescents could earn escalating prize drawing opportunities by completing verifiable pro-social activities and providing negative urine test and breath alcohol test results. |
| ACC + CM | Experimental | Behavioral: ACC, Behavioral: CM, Behavioral: UCCThis arm is the combination of arms 1 and 2. |
| Usual Continuing Care (UCC) | Active comparator | Behavioral: UCCUCC consists of a discharge recommendation to seek aftercare services at nearest treatment provider to where the patient lived. This service primarily consisted of outpatient group counseling. |
Who may qualify
- Ages
- 12 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (2 listed)
- Met DSM-IV diagnostic criteria for abuse or dependence on alcohol or another drug in the past year
- Been between the ages of 12 and 18 at the time of residential admission; and (c) resided in one of ten Illinois counties targeted for the intervention
Key exclusion criteria (8 listed)
- left residential treatment prior to the seventh day
- did not return to a target county at discharge
- showed evidence of cognitive impairment that interfered with understanding of study instruments, procedures, or the informed consent process
- were deemed dangerous to themselves or others during treatment
- were a ward of child protective services and inaccessible for the intervention
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ACCWeekly community based behavioral counseling and case management | Behavioural | ACC + CM, Assertive Continuing Care (ACC) |
| CMWeekly community based prize drawing opportunities contingent upon completed verifiable pro-social activities and clean urine and breath alcohol test results | Behavioural | ACC + CM, Contingency Management (CM) |
| UCCrecommendation made by discharge counselor upon leaving residential treatment to attend nearest outpatient clinic. | Behavioural | ACC + CM, Assertive Continuing Care (ACC), Contingency Management (CM), Usual Continuing Care (UCC) |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2010.
Related trials for Substance Use Disorders
Enrolling by invitationObservational study
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Substance Use Disorders (SUDs)
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Recruiting
Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems
Alcohol Use, Adolescent
Enrolling by invitation
PATH to Reducing Burnout Among Peers Who Deliver Overdose Prevention Services (R33 Phase Clinical Trial)
Burnout, Secondary Trauma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing ACC, CM and UCC in people with Substance Use Disorders, run by Chestnut Health Systems.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Mar 2010. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2010; AzTrials last refreshed its copy on 30 Oct 2026.